DCIS incidence is highly increased since population-based breast cancer screening. There is strong evidence that breast cancer screening results in overdiagnosis of DCIS. We are unable to predict the individual risk of DCIS progression into invasive carcinoma. Distinguishing harmless from potentially hazardous DCIS is essential to offer customized therapy in the future.